Despite preparative work by the bio/pharma industry, any Brexit scenario will result in regulatory implications and increased costs.
Vincenzo Salvatore
Advertisement
Vincenzo Salvatore is team leader Healthcare and Life Sciences Focus Team, BonelliErede.
Articles by Vincenzo Salvatore
Advertisement
Latest Updated Articles
The Cost of BrexitNovember 2nd 2019
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
PharmTech Weekly Roundup—June 5, 2026
5